Jun 02, 2023 / 08:00PM GMT
Presentation
Jun 02, 2023 / 08:00PM GMT
=====================
Corporate Participants
=====================
* Christian Martin Itin
Autolus Therapeutics plc - CEO & Director
* Julia Wilson
=====================
Conference Call Participants
=====================
* Asthika Sarith Goonewardene
Truist Securities, Inc., Research Division - Research Analyst
* Dingding Shi
Jefferies LLC, Research Division - Equity Analyst
* Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst
* Gil Joseph Blum
Needham & Company, LLC, Research Division - Senior Analyst
* Mara Goldstein
Mizuho Securities USA LLC, Research Division - MD of Equity Research Department
* Matthew Christopher Phipps
William Blair & Company L.L.C., Research Division - Senior Biotechnology Research Analyst
* Rajan Sharma
Goldman Sachs Group, Inc., Research Division - Research Analyst
* Yanan Zhu
Wells Fargo Securities, LLC, Research Division
Autolus Therapeutics PLC
(FRA:6A3A)
€
2.22
-0.1 (-4.31%)
Market Cap: 590.79 Mil
Enterprise Value: 656,000.00
PE Ratio: 0
PB Ratio: 1.28
GF Score: 49/100 Autolus Therapeutics PLC ASCO Oral Presentation Transcript
Jun 02, 2023 / 08:00PM GMT
Release Date Price:
€2.7
(-3.57%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot